. 2010 Mar;5(3):439–444. doi: 10.2215/CJN.07571009

Table 2.

Clinical findings at biopsy and follow-up in patients of mercury-induced MN

Case	Hb, g/dl	BUN, mg/dl	SCr, mg/dl	UA, μmol/L	Alb, g/L	Glo, g/L	TC, mmol/L	TG, mmol/L	Urinary Protein, g/24 h	Urinary NAG, U/g per creatinine	Urinary RBP, mg/L	Osmolality, mOsm/kg H₂O	ANA	Treatment	Follow-Up, mo	Last Follow-Up
Case	Hb, g/dl	BUN, mg/dl	SCr, mg/dl	UA, μmol/L	Alb, g/L	Glo, g/L	TC, mmol/L	TG, mmol/L	Urinary Protein, g/24 h	Urinary NAG, U/g per creatinine	Urinary RBP, mg/L	Osmolality, mOsm/kg H₂O	ANA	Treatment	Follow-Up, mo	Urinary Protein, g/24 h	Alb, g/L	SCr, mg/dl
1	9.7	6.35	0.41	244	27.5	24.8	4.03	1.29	2.08	40.4	0.38	594	1:128	DMPS	48	0.18	45.1	0.50
2	9.0	28.2	0.70	180	31.6	17.2	5.54	0.79	1.86	42.2	0.23	541	N	DMPS	6	0.78	38.5	0.61
3	13.6	13.5	0.47	257	35.5	24.3	9.78	1.83	1.2	22.2	0.6	1002	1:16		30	0.11	49.0	0.52
4	14.8	10.2	0.51	286	42	27.5	4.79	2.24	1.49	35.3	0.21	1158	N		18	0.12	43.9	0.61
5	12.8	10.5	0.56	347	21.3	16.2	7.25	1.86	3.82	29.3	0.17	782	N	ACEI	24	0.15	47.1	0.43
6	12.5	8.52	0.63	369	29.9	23.2	3.86	2.77	3.17	46.3	0.05	772	1:512	ARB	12	0.13	41.2	0.58
7	12.2	7.34	0.49	213	25	17.6	5.25	0.91	2.39	37.1	0.08	739	N	DMPS	14	0.36	41.2	0.58
8	13.1	11.3	0.85	406	26.1	15.1	5.15	0.96	3.52	27.5	0.09	666	N	ARB	12	0.10	43.5	0.68
9	13.2	14.1	0.87	396	34.1	22.8	5.47	1.01	1.43	23.9	0.12	667	1:4	ARB	48	0.10	45.8	0.58
10	12.1	8.12	0.64	348	27.2	22.8	4.4	2.17	3.1	85.5	2.77	604	N	DMPS	36	0.10	48.6	0.64
11	14.1	5.23	0.51	271	21.1	21.7	10.56	2.96	4.76	52.3	0.13	682	N	ARB	6	1.78	36.9	0.46

Hb, hemoglobin; BUN, blood urea nitrogen; SCr, serum creatinine; UA, uric acid; Alb, albumin; Glo, globulin; TC, total cholesterol; TG, total triglyceride; ANA, anti-nuclear antibody; NAG, N-acetyl-pd-glucosaminidase enzyme; N, negative; DMPS, sodium dimercaptopropane sulfonate; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.